TORONTO, Feb 19, 2001 (LSN.ca) -Paladin Labs, the Montreal-based company that is marketing the abortifacient morning-after pill Plan B on the Canadian market, has announced that the Ontario Drug Benefit Program has confirmed it will list Plan B as of March 7, 2001. Thus the abortifacient will be provided for low income Canadians and those in special care. The press release reports that Plan B is also covered by drug plans in Quebec and BC.
See the Paladin press release at: https://www.paladin-labs.com/e/pr79.htm
$